Related Experiment Videos
Polymorphic ventricular tachycardia in the coronary care unit.
Philip Varriale1, Marino Leonardi
1Division of Cardiology, Cabrini Medical Center of New York, New York, New York, USA.
Heart & Lung : the Journal of Critical Care
|July 26, 2006
Summary
Polymorphic ventricular tachycardia (PMVT) can lead to cardiac arrest, even without QTc prolongation. Prompt identification and treatment of the underlying cause are crucial for improving patient outcomes and managing this dangerous arrhythmia.
Area of Science:
- Cardiology
- Electrophysiology
- Internal Medicine
Background:
- Polymorphic ventricular tachycardia (PMVT) is a serious arrhythmia with potentially malignant outcomes.
- Understanding the clinical presentation and management of PMVT is essential for effective patient care.
Purpose of the Study:
- To describe the clinical experience of patients with polymorphic ventricular tachycardia (PMVT) in a hospital setting.
- To analyze etiologic factors, management strategies, and clinical outcomes of PMVT patients.
Main Methods:
- A 2-year prospective, observational study involving patients with symptomatic and asymptomatic PMVT.
- Electrocardiogram analysis to diagnose PMVT and determine QTc interval.
- Review of etiologic factors, management, and clinical outcomes.
Main Results:
- The study included 27 patients, with PMVT occurring in those with prolonged QTc intervals (n=14) and normal QTc intervals (n=10).
- Common causes included hypokalemia with underlying heart disease (acquired QT syndrome) and acute myocardial infarction (normal QTc).
- Cardiac arrest requiring defibrillation was the predominant presentation (63%), with a 15% mortality rate.
Conclusions:
- PMVT, with or without QTc prolongation, is a sporadic tachyarrhythmia with a high risk of cardiac arrest.
- Effective management requires emergency defibrillation for cardiac arrest and specific therapies to suppress PMVT.
- Correctly identifying and promptly treating the cause of PMVT significantly improves prognosis.